MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Intention Awareness in Parkinson’s Disease

    S. Di Costa, E. Barow, C. Moll, U. Hidding, O. Fründt, C. Gerloff, R. Erro, M. Pötter-Nerger, C. Buhmann, P. Haggard, C. Ganos (LONDON, United Kingdom)

    Objective: To investigate the role of dopamine in intention awareness of voluntary actions in patients with Parkinson’s Disease (PD). Background: Underactivation of the SMA due…
  • 2017 International Congress

    SNCA multiplication consortium: Clinicogenetic analysis of SNCA multiplication probands and families.

    A. Book, M. Farrer, T. Candido, I. Guella, D. Evans, E. Gustavsson (Vancouver, BC, Canada)

    Objective: Clinicogenetic analysis of 57 affected probands with SNCA multiplication, 3 unaffected carriers, and their 60 families. To use informative pedigrees to identify penetrance modifiers…
  • 2017 International Congress

    Parkinsonian Features in a Cohort of Gaucher’s Disease (GD) Patients and Relatives.

    I. Trezzi, E. Monfrini, G. Buongarzone, E. Cassinerio, I. Motta, F. Nascimbeni, F. Carubbi, N. Bresolin, G. Comi, M. Cappellini, A. Di Fonzo (Milan, Italy)

    Objective: to investigate the prevalence and clinical features of parkinsonism in a cohort of 21 GD patients and their relatives. Background: GD is a lysosomal…
  • 2017 International Congress

    Short term effects of bilateral STN DBS on psychiatric profile in Parkinson’s disease

    R. Alugolu, M.B. Kesani, B. Ganji, V. Mudumba, R. Mrudula, R. Borgohain, P. Gaddamanugu (Hyderabad, India)

    Objective: We intend to look into the effects of bilateral STN DBS on Psychiatric profile of Parkinson’s patients. Background: Parkinson’s disease is a well-known degenerative…
  • 2017 International Congress

    Assessing Bone Health in Parkinson’s – When and how?

    A. Dzharif, E. Thomas, B. Mohamed, T. Williams, S. Mahon (Cardiff, United Kingdom)

    Objective: To assess the impact of, and practicality of, assessing bone health routinely in people newly diagnosed with Parkinson’s disease in a South Wales University…
  • 2017 International Congress

    PROMESA: Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach – evaluation of serious adverse events

    M. Schuberth, J. Levin, S. Maaß, G. Respondek, K. Bötzel, G. Höglinger (Muenchen, Germany)

    Objective: In the PROMESA trial (ClinicalTrials Identifier: NCT02008721) Epigallocatechingallate (EGCG) a catechine that prevents pathological protein aggregation in vitro and can be purified from green…
  • 2017 International Congress

    The management of Parkinson’s disease in the Middle East countries: the MDS-middle east task force survey

    H. Khalil, Z. Aldaajani, S. Baudry, M. Abualmelh, T. Mohammad, M. Salari, M. Bhatt, S. Tabbal, N.A. Syed, B. Jeon, C. Goetz, J.A. Bajwa (Irbid, Jordan)

    Objective: The movement disorders society task force for the Middle East (MDS-Task Force for the Middle East) conducted a survey with an aim of characterizing…
  • 2017 International Congress

    Istradefylline for daytime sleepiness and sleep disturbances in patients with Parkinson’s disease: an open-label, 3-month study

    K. Suzuki, M. Miyamoto, T. Miyamoto, T. Uchiyama, Y. Watanabe, T. Kadowaki, K. Hirata (Mibu, Japan)

    Objective: To evaluate the effect of istradefylline on daytime sleepiness and sleep disturbances as well as motor symptoms in patients with Parkinson’s disease (PD) in…
  • 2017 International Congress

    Improvement on gait in Parkinson’s disease patients using Honda stride management assist device

    N. Kawashima, M. Matsuhashi, T. Hamano, K. Nagami, T. Furukado, M. Iijima, M. Isogai, M. Komachi, A. Kumon, K. Miyashita, A. Sato, K. Hasegawa (Fujisawa, Japan)

    Objective: To clarify the effect of a wearable exoskeleton stride management assist device (SMAD: Honda R and D Corporation, Japan) on gait in Parkinson's disease…
  • 2017 International Congress

    Focused ultrasound subthalamotomy for Parkinson’s disease: A pilot study

    R. Martinez-Fernandez, R. Rodriguez-Rojas, M. del Álamo, F. Hernandez, J.A. Pineda-Pardo, M. di Leone, F. Alonso, I. Obeso, C. Gasca-Salas, E. de Luis, L. Vela, J.A. Obeso (Mostoles, Spain)

    Objective: To evaluate feasibility, safety and effectiveness of unilateral subthalamotomy performed with MRIgHIFU to treat the cardinal motor features of PD Background: Ablative functional neurosurgery for…
  • « Previous Page
  • 1
  • …
  • 311
  • 312
  • 313
  • 314
  • 315
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley